We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
MGNX -- MacroGenics
An SI Board Since November 2013
Posts SubjectMarks Bans Symbol
180 26 0 MGNX
Emcee:  scaram(o)uche Type:  Moderated
CD123-related abstract (preclinical) coming up at ASH, so maybe it's time for a thread. DART is a very old concept.... I was one of the first to try it, but the original concept came from Dartmouth and served as the foundation science for Medarex.

MGD006, Servier has right to license for some geographies.....

One more ASH abstract, not from MGNX.......

Pointer to the pipeline chart, website.....

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
180<PS: I am pissed that my 32.6 order did not went true....other than that, fewMiljenko Zuanic-June 5
179>> n=62 for the V/V population vs. 437 for FF/FV << Conference callscaram(o)uche-June 4
178As I've mentioned on more that one occasion, I have held very few shares....scaram(o)uche1June 4
177I am out!Miljenko Zuanic-June 4
176TERRIBLE OS KM curve: twitter.comMiljenko Zuanic-June 4 Marg positive, not very big but posite, on several measuremenMiljenko Zuanic-May 16
174Marg pre-clinical at AACR-2019: ir.macrogenics.comMiljenko Zuanic-April 3
173AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antinigel bates-March 29
172If they want any return for Merg, they need to accelerate filling. Competitor: dMiljenko Zuanic-March 28
171RE: Teplizumab (anti-CD3 for autoimmune T1D) : clinicaltrials.govMiljenko Zuanic-March 28
170For the first February 15 days, short interest is reduced by 1.5m shares (35%), Miljenko Zuanic-March 2
169Manufacturing We currently manufacture our drug substance for our clinical trialMiljenko Zuanic-February 27
168Many *street oncology experts* were quick to point that luck of absolute numbersMiljenko Zuanic-February 25
167FUCx WG, and many others, who think that by blocking me will gain something, insMiljenko Zuanic-February 24
166Instead, they waited a week to launch their secondary. They didn't seek fuDewDiligence_on_SI-February 23
165Commenting on the recent "data"..... William Gerber is cscaram(o)uche-February 23
164You are right, 012 is hinge-stabilized ( ), and they did not Miljenko Zuanic1February 19
163Oh wow. Thank you! I had seen the CCR publication, but didn't consider itsscaram(o)uche-February 19
162That is improvement from cc time-point. INCY need INCMGA00012 to work, so they cMiljenko Zuanic-February 19
161MCC trial...... all sites now listed as recruiting. And POD1UM-203 is also nscaram(o)uche-February 18
160INCY 4Qr-cc, nothing new on INCMGA0012, are they still on p2 dose confirmation QMiljenko Zuanic-February 14
1595.5M + 0.82 at 20. For those who may be interested on speculation around Marg mMiljenko Zuanic1February 12
158<Why did they wait 6 days?> My make Leerink's and Evercore&Miljenko Zuanic-February 12
157Why did they wait 6 days?DewDiligence_on_SI-February 12
156secondary...expected Zuanic-February 12
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):